PMC6252232_01
First bone marrow biopsy showing normo/hypercellularity.
CRIHEM2018-9750532.001.jpg
PMC6252232_01_CRIHEM2018-9750532.001.jpg
fig1
The diagnosis remained that of myelodysplasia of refractory anemia (Figure 1).
Coronal sections Uro-CT scan with contrast showing filling defect (arrows).
CRIHEM2018-9750532.002.jpg
PMC6252232_01_CRIHEM2018-9750532.002.jpg
fig2
An excretion CT scan of the urinary system revealed a lobulated lesion in the region of the left ureteral meatus with a diameter of 16 mm (Figures 2 and 3).
Sagittal section Uro-CT scan showing proliferative lesion left ureteral meatus (arrow).
CRIHEM2018-9750532.003.jpg
PMC6252232_01_CRIHEM2018-9750532.003.jpg
fig3
An excretion CT scan of the urinary system revealed a lobulated lesion in the region of the left ureteral meatus with a diameter of 16 mm (Figures 2 and 3).
Four tumors seen at initial cystoscopy.
CRIHEM2018-9750532.004.jpg
PMC6252232_01_CRIHEM2018-9750532.004.jpg
fig4
Trends in hemoglobin levels and platelet counts with time.
CRIHEM2018-9750532.005.jpg
PMC6252232_01_CRIHEM2018-9750532.005.jpg
fig5
One month after completing BCG treatment, both the hemoglobin level and platelet counts were decreasing, and six months later, the patient had a hemoglobin level of 8.5 gr/dl, MCV 113, and a platelet count of 26,000 (Figure 5).
Repeated bone marrow biopsy showing marked decreased cellularity in comparison with the first biopsy.
CRIHEM2018-9750532.006.jpg
PMC6252232_01_CRIHEM2018-9750532.006.jpg
fig6
A repeat bone marrow biopsy showed a hypocellular bone marrow, with between 30% and 50% of the intertrabecular spaces being occupied by hematopoietic tissue (Figure 6).
Bone marrow, negative for micrometastasis.
CRIHEM2018-9750532.007.jpg
PMC6252232_01_CRIHEM2018-9750532.007.jpg
fig7